Dopamine agonist therapy in low-response children following traumatic brain injury

Journal of Child Neurology

Volumn 21, Issue 10, 2006, Pages 879-885

  Patrick, Peter D ^a   Blackman, James A ^a   Mabry, Jennifer L ^a   Buck, Marcia L ^a   Gurka, Matthew J ^b   Conaway, Mark R ^b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; AMITRIPTYLINE; ATENOLOL; BACLOFEN; CLONIDINE; DIAZEPAM; DOPAMINE RECEPTOR STIMULATING AGENT; ETIRACETAM; LORAZEPAM; METHADONE; PRAMIPEXOLE; PROPRANOLOL; VALPROIC ACID;

ADOLESCENT; ADULT; AROUSAL; ARTICLE; AWARENESS; CLINICAL ARTICLE; CLINICAL TRIAL; COMMUNICATION SKILL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG DOSE ESCALATION; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG RESPONSE; DRUG WITHDRAWAL; FEMALE; FUNCTIONAL ASSESSMENT; FUNCTIONAL STATUS; HUMAN; MALE; MENTAL HEALTH; PRIORITY JOURNAL; RANCHO LOS AMIGOS SCALE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; REHABILITATION CARE; SCHOOL CHILD; SEDATION; SIDE EFFECT; TRAUMATIC BRAIN INJURY; TREMOR;

ADOLESCENT; ADULT; AMANTADINE; BENZOTHIAZOLES; BRAIN INJURIES; CHILD; DISABILITY EVALUATION; DOPAMINE AGONISTS; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; GLASGOW COMA SCALE; HUMANS; MALE; OUTCOME ASSESSMENT (HEALTH CARE); PROSPECTIVE STUDIES; TIME FACTORS;

EID: 33846207507     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/08830738060210100901     Document Type: Article

References (28)

1. Hagen C, Malkmus D, Durham P: Levels of Cognitive Functioning. Downey, CA, Rancho Los Amigos Hospital, 1979.
2. The Multi-Society Task Force on PVS: Medical aspects of the persistent vegetative state; first of two parts. N Engl J Med 1994;330:1499-1507.
3. Tang Y-P, Noda Y, Nabeshima T: Involvement of activation of dopaminergic neuronal system in learning and memory deficits associated with experimental mild traumatic brain injury. Eur J Neurosci 1997;9:1720-1727.
4. Adams JH, Graham DI, Jennett B: The neuropathology of the vegetative state after an acute brain insult. Brain 2000;123:1327-1338.
5. Lal S, Merbitz CP, Grip JC: Modification of function in head-injured patients with Sinemet. Brain Inj 1988;2:225-233.
6. Van Woerkom TCAM, Minderhound JM, Gottschal T, Nicolai G: Neurotransmitters in the treatment of patients with severe head injuries. Eur Neurol 1982;21:227-234.
7. Povlishock JT: Pathophysiology of neural injury: Therapeutic opportunities and challenges. Clin Neurosurg 2000;46:113-126.
8. Schneider WN, Drew-Cates J, Wong TM, Dombovy ML: Cognitive and behavioral efficacy of amantadine in acute traumatic brain injury: An initial double blind placebo-controlled study. Brain Inj 1999;13:863-872.
9. McDowell S, Whyte J, D'Esposito M: Differential effect of a dopaminergic agonist on prefrontal function in traumatic brain injury patients. Brain 1998;121:11551164.
10. Karli DC, Burke DT, Kim HJ, et al: Effects of dopaminergic combination therapy for frontal lobe dysfunction in traumatic brain injury rehabilitation. Brain Inj 1999;13:63-68.
11. Waxham MN: Neurotransmitter receptors, in Zigmond MJ, Bloom FE, Landis SC, et al (eds): Fundamental Neuroscience. San Diego, Academic Press, 1999, 235-267.
12. Penny JB: Neurochemical neuroanatomy, in Fogel BS, Schiffer RB, Rao SM (eds): Neuropsychiatry. Baltimore, Williams and Wilkins, 1996, 145-171.
13. Schatzberg AF, Nemeroff CB: Textbook of Psychopharmacology. The American Psychiatric Publishing, Washington, DC, 2003.
14. Ansell BJ, Keenan JE: The Western Neuro Sensory Stimulation Profile: A tool for assessing slow-to-recover head-injured patients. Arch Phys Med Rehabil 1989;70:104-108.
15. Patrick PD, Buck ML, Conaway MR, Blackman JA. The use of dopamine enhancing medications with children in low response states following brain injury. Brain Inj 2003;17:497-506.
16. Nickels JL, Schneider WN, Dombovy ML, Wong TM: Clinical use of amantadine in brain injury rehabilitation. Brain Inj 1994;8:709-718.
17. Gaultieri CTCM, Coons-Brown L: Amantidine: A new clinical profile for traumatic brain injury. Clin Neurophamacol 1989;12:258-270.
18. Meythaler JM, Brunner RC, Johnson A, Novack TA: Amantadine to improve neurorecovery in traumatic brain injury-associated diffuse axonal injury: A pilot double-blind randomized trial. J Head Trauma Rehabil 2002;17:300-313.
19. Green LB, Hornyak JE, Hurvitz EA: Amantadine in pediatric patients with traumatic brain injury: A retrospective, case-controlled study. Am J Phys Med Rehabil 2004;83:893-897.
20. Gerlach M, Double K, Arzberger T, et al: Dopamine receptor agonists in current clinical use: Comparative dopamine receptor binding profiles defined in the human striatum. J Neural Transm 2003;110:1119-1127.
21. Parkinson Study Group: Safety and efficacy of pramipexole in early Parkinson disease. A randomized dose-ranging study. JAMA 1997;278:125-130.
22. O'Dell MW, Riggs RV. Management of the minimally responsive patient, in Horn LJ, Zasler ND (eds): Medical Rehabilitation of Traumatic Brain Injury. Philadelphia, Hanley & Belfus, 1996, 103-132.
23. Rappaport M, Dougherty AM, Kelting DL: Evaluation of coma and vegetative states. Arch Phys Med Rehabil 1992;73:628-634.
24. Rappaport M, Hall KM, Hopkins K, et al: Disability rating scale for severe head trauma: Coma to community. Arch Phys Med Rehabil 1982;63:118-123.
25. Hollander M, Wolfe DA: Nonparametric Statistical Methods. New York John Wiley and Son, 1973.
26. Blackman JA, Patrick PD, Buck ML, Rust RS: Paroxysmal autonomic instability with dystonia after brain injury [erratum appears in Arch Neurol 2004 Jun;61(6):980]. Arch Neurol 2004;61:321-328.
27. Passler MA, Riggs RV: Positive outcomes in traumatic brain injury-vegetative state: Patients treated with bromocriptine. Arch Phys Med Rehabil 2001;82:311-315.
28. Kearns GL, Abdel-Rahman SM, Alander SW, et al: Developmental pharmacology - Drug disposition, action, and therapy in infants and children. N Engl J Med 2003;349:1157-1167.